Novo Nordisk A/S (ADR) (NVO): Insiders Aren’t Crazy About It

Page 1 of 2

Novo Nordisk A/S (ADR) (NYSE:NVO) was in 13 hedge funds’ portfolio at the end of the first quarter of 2013. NVO shareholders have witnessed a decrease in support from the world’s most elite money managers lately. There were 14 hedge funds in our database with NVO positions at the end of the previous quarter.

At the moment, there are dozens of metrics shareholders can use to analyze the equity markets. A duo of the most useful are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite fund managers can outperform their index-focused peers by a healthy margin (see just how much).

Novo Nordisk A/S (ADR) (NYSE:NVO)Equally as integral, bullish insider trading activity is another way to parse down the marketplace. There are many incentives for a corporate insider to drop shares of his or her company, but only one, very obvious reason why they would behave bullishly. Various empirical studies have demonstrated the useful potential of this method if piggybackers understand where to look (learn more here).

Keeping this in mind, we’re going to take a gander at the latest action surrounding Novo Nordisk A/S (ADR) (NYSE:NVO).

What have hedge funds been doing with Novo Nordisk A/S (ADR) (NYSE:NVO)?

In preparation for this quarter, a total of 13 of the hedge funds we track were bullish in this stock, a change of -7% from the previous quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a select group of notable hedge fund managers who were increasing their holdings considerably.

According to our comprehensive database, Ken Fisher’s Fisher Asset Management had the biggest position in Novo Nordisk A/S (ADR) (NYSE:NVO), worth close to $430.7 million, comprising 1.1% of its total 13F portfolio. On Fisher Asset Management’s heels is Jim Simons of Renaissance Technologies, with a $424.4 million position; 1% of its 13F portfolio is allocated to the stock. Some other hedge funds with similar optimism include Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, Tom Gayner’s Markel Gayner Asset Management and Israel Englander’s Millennium Management.

Judging by the fact that Novo Nordisk A/S (ADR) (NYSE:NVO) has experienced falling interest from the aggregate hedge fund industry, logic holds that there is a sect of money managers that decided to sell off their entire stakes heading into Q2. It’s worth mentioning that Mike Vranos’s Ellington said goodbye to the biggest stake of all the hedgies we track, worth about $0.9 million in stock.. Murray Stahl’s fund, Horizon Asset Management, also dumped its stock, about $0.3 million worth. These transactions are interesting, as total hedge fund interest fell by 1 funds heading into Q2.

How are insiders trading Novo Nordisk A/S (ADR) (NYSE:NVO)?

Insider purchases made by high-level executives is best served when the primary stock in question has seen transactions within the past half-year. Over the last 180-day time frame, Novo Nordisk A/S (ADR) (NYSE:NVO) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Novo Nordisk A/S (ADR) (NYSE:NVO). These stocks are Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY), Pharmacyclics, Inc. (NASDAQ:PCYC), Forest Laboratories, Inc. (NYSE:FRX), Allergan, Inc. (NYSE:AGN), and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). This group of stocks belong to the drug manufacturers – other industry and their market caps are similar to NVO’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!